Total Clarity Wealth Management »

Bridgebio Pharma shares owned by Total Clarity Wealth Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Total Clarity Wealth Management from 13F filings

Historical chart of Total Clarity Wealth Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Total Clarity Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Total Clarity Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $226k 4.4k 51.94

More positions owned by Total Clarity Wealth Management

Spdr Series Trust Portfolio S&p500 (SPLG)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Wisdomtree Tr Floatng Rat Trea (USFR)
Vanguard Index Fds Sm Cp Val Etf (VBR)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
NVIDIA Corporation (NVDA)
Spdr Series Trust Portfolio Agrgte (SPAB)
Apple (AAPL)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Invesco Exch Traded Fd Tr Ii Equal Wegt 0-30 (GOVI)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Ishares Tr Rus 1000 Grw Etf (IWF)
Invesco Actively Managed Exc Total Return (GTO)
Microsoft Corporation (MSFT)
Invesco Actively Managed Exc Var Rate Invt (VRIG)

View all positions for Total Clarity Wealth Management

Top funds holding Bridgebio Pharma

Vanguard Group
Viking Global Investors
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Susquehanna International
Invesco
Geode Capital Management
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma